Author

Akira Nishio

Institutions: Osaka Hospital, Japan Community Healthcare Organization, The University of Osaka

Observed institutions: Osaka Hospital, Japan Community Healthcare Organization, The University of Osaka

ORCID: 0000-0003-1668-0779

Observed ORCID: 0000-0003-1668-0779

OpenAlex ID: A5123133686

NRF2–COX2–PGE2 axis drives immune cold tumors and predicts resistance to combination immunotherapy in hepatocellular carcinoma

2026 · Shuhei Yamamoto, Takahiro Kodama, et al. · Hepatology · 7

Systemic immune profiling uncovers divergent mechanisms and predictive biomarkers of response to combination immunotherapies in hepatocellular carcinoma

2026 · Akira Nishio, Takahiro Kodama, et al. · Journal for ImmunoTherapy of Cancer · 3

Carbonic anhydrase 9 as a circulating biomarker and therapeutic target in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab

2026 · Yu Sato, Takahiro Kodama, et al. · Journal for ImmunoTherapy of Cancer · 1

Ciliated Hepatic Foregut Cyst With Clustered Echogenic Foci: An Incidental Finding on Health Screening

2026 · Yuka Miyoshi, Akira Nishio, et al. · The American Journal of Gastroenterology

Works count: 4

Citation count: 11

H-index: 2

I10-index: